Genesis Peptides

Genesis Peptides is a research peptide supplier with over 74 active listings on Peptides.SO, positioned in the U.S. domestic research compound market with a catalog that covers the principal peptide research families studied in growth hormone biology, tissue repair, metabolic regulation, and longevity research. The company's brand emphasizes foundational catalog coverage of the core research peptide segments with a focus on purity-verified supply for the academic and independent research communities.

The Genesis Peptides catalog spans all primary research peptide compound categories. Growth hormone secretagogue coverage includes the complete standard GHRH and GHRP analogue stack: CJC-1295 (with and without DAC), Ipamorelin, GHRP-2, GHRP-6, Hexarelin, and Sermorelin. These compounds are studied in hypothalamic-pituitary axis signaling, GH pulse pattern modulation, IGF-1 secretion, and GH-related metabolic effects in preclinical research models. Tesamorelin and AOD-9604 extend GH-axis coverage into metabolic biology and GH fragment peptide research.

Tissue repair and regeneration peptides include BPC-157 and TB-500 in standard vial formats and blended combinations. BPC-157 research literature covers gastrointestinal mucosal protection, tendon and ligament repair, and systemic anti-inflammatory effects. TB-500 (Thymosin Beta-4) has been studied in cardiac tissue repair, wound healing acceleration, and inflammation resolution in animal models. Multiple vial sizes support different experimental scale requirements.

GLP-1 receptor agonist research compounds include Semaglutide, Tirzepatide, and Liraglutide, covering the contemporary GLP-1 pharmacology research space relevant to insulin secretion, appetite regulation, and metabolic disease biology. Melanocortin peptides (Melanotan-I, Melanotan-II, PT-141) serve researchers in pigmentation biology and CNS melanocortin receptor studies.

Longevity and bioregulator compound coverage includes Epithalon, Thymosin Alpha-1, Thymalin, and GHK-Cu — compounds studied across telomere biology, thymic function, immune modulation, and connective tissue research domains. Cognitive peptides Semax and Selank serve researchers investigating neuroprotection and nerve growth factor signaling in preclinical models.

Genesis Peptides carries the deepest verified bioregulator-peptide pricing coverage in this batch: Vilon and Oxytocin at $2.00/mg, Chonluten and Vesugen at $2.75/mg, Cardiogen, Prostamax, and Testagen each at $3.25/mg, and Livagen/Ovagen at $6.25/mg, with the broader catalog ranging up to $23.50/mg for PEG-MGF and $17.00/mg for Survodutide. The tight $2-$6.25/mg clustering across its bioregulator line suggests uniform per-vial margins across that product family rather than compound-by-compound pricing, giving researchers a predictable cost basis when sourcing multiple bioregulator peptides from Genesis in a single order.

Third-party HPLC and mass spectrometry analysis provides purity verification per product, with COA documentation available. All Genesis Peptides products are sold exclusively for laboratory research and in-vitro scientific investigation purposes. They are not approved for human or veterinary consumption, and all handling should conform to applicable institutional research protocols.